RecruitingNCT06356272
Oropharynx (OPX) Biomarker Trial
Sponsor
Mayo Clinic
Enrollment
560 participants
Start Date
Nov 15, 2019
Study Type
OBSERVATIONAL
Conditions
Head and Neck CarcinomaClinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Oropharyngeal Squamous Cell CarcinomaStage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8Oropharyngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell CarcinomaHead and Neck NeoplasmSalivary Gland NeoplasmsThyroid Gland Neoplasm
Summary
The purpose of this research is to identify a biomarker that is exists when human papillomavirus (HPV) mediated oropharyngeal squamous cell carcinoma is present and does not exist when HPV mediated oropharyngeal squamous cell carcinoma is absent.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study collects detailed biological information (biomarkers) from patients with cancers of the throat and mouth area — particularly oropharyngeal cancers related to HPV — to better understand how these tumors behave and how to predict who will respond well to treatment.
**You may be eligible if...**
- You are 18 or older and able to provide written consent
- You have been diagnosed with, or are suspected to have, a cancer or abnormal growth in the head and neck area (including throat, mouth, thyroid, or salivary glands)
- You are willing to have your tumor tissue, blood, and/or saliva samples used for research
- You can complete questionnaires (alone or with help)
**You may NOT be eligible if...**
- You are currently enrolled in another cancer treatment trial
- You have had another active cancer within the past 5 years (with some exceptions for early-stage or cured cancers)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNon-Interventional Study
Non-interventional study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06356272
Related Trials
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
NCT04671667177 locations
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
NCT05136196221 locations
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
NCT0719573440 locations
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
NCT06589804176 locations
Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
NCT045649893 locations